CL stock icon

Colgate-Palmolive
CL

$91.94
1.46%
 

About: Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's, which primarily sells its products through veterinarians and specialty pet retailers.

Employees: 34,000

0
Funds holding %
of 6,665 funds
0
Analysts bullish %
of 20 analysts
0
News positive %
of 21 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

204% more call options, than puts

Call options by funds: $1,000M | Put options by funds: $329M

13% more capital invested

Capital invested by funds: $52.9B [Q4 2023] → $59.8B (+$6.95B) [Q1 2024]

0.36% more ownership

Funds ownership: 80.48% [Q4 2023] → 80.83% (+0.36%) [Q1 2024]

0% less funds holding

Funds holding: 1,701 [Q4 2023] → 1,699 (-2) [Q1 2024]

1% less first-time investments, than exits

New positions opened: 145 | Existing positions closed: 147

10% less funds holding in top 10

Funds holding in top 10: 10 [Q4 2023] → 9 (-1) [Q1 2024]

20% less repeat investments, than reductions

Existing positions increased: 549 | Existing positions reduced: 687

Research analyst outlook

20 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$82
11%
downside
Avg. target
$93
1%
upside
High target
$107
16%
upside

20 analyst ratings

14 positive
70%
neutral
30%
negative
0%
Morgan Stanley
Dara Mohsenian
12%upside
$103
Overweight
Maintained
28 May 2024
Argus Research
Chris Graja
16%upside
$107
Buy
Maintained
15 May 2024
Barclays
Lauren Lieberman
8%downside
$85
Equal-Weight
Maintained
30 Apr 2024
Wells Fargo
Chris Carey
0%upside
$92
Equal-Weight
Maintained
29 Apr 2024
Stifel
Mark Astrachan
3%upside
$95
Buy
Maintained
29 Apr 2024

Financial journalist opinion

Based on 21 articles about CL published over the past 30 days